Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model

INTRODUCTION: Recombinant human soluble thrombomodulin (rhsTM) is newly developed for the treatment of DIC. The purpose of this study was to evaluate the efficacy of the concomitant administration of rhsTM and antithrombin (AT). METHODS: In the first series, rats were treated with either 62.5, 125,...

Descripción completa

Detalles Bibliográficos
Autores principales: Iba, Toshiaki, Nakarai, Etsuro, Takayama, Toshio, Nakajima, Kenji, Sasaoka, Tetsumasa, Ohno, Yoichi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811901/
https://www.ncbi.nlm.nih.gov/pubmed/20003418
http://dx.doi.org/10.1186/cc8210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811901/
https://www.ncbi.nlm.nih.gov/pubmed/20003418
http://dx.doi.org/10.1186/cc8210

Ejemplares similares